Background: The goal of this pilot study was to evaluate the effects of the cognitive-restructuring technique ‘lucid dreaming treatment’ (LDT) on chronic nightmares. Becoming lucid (realizing that one is dreaming) during a nightmare allows one to alter the nightmare storyline during the nightmare itself. Methods: After having filled out a sleep and a posttraumatic stress disorder questionnaire, 23 nightmare sufferers were randomly divided into 3 groups; 8 participants received one 2-hour individual LDT session, 8 participants received one 2-hour group LDT session, and 7 participants were placed on the waiting list. LDT consisted of exposure, mastery, and lucidity exercises. Participants filled out the same questionnaires 12 weeks after the intervention (follow-up). Results: At follow-up the nightmare frequency of both treatment groups had decreased. There were no significant changes in sleep quality and posttraumatic stress disorder symptom severity. Lucidity was not necessary for a reduction in nightmare frequency. Conclusions: LDT seems effective in reducing nightmare frequency, although the primary therapeutic component (i.e. exposure, mastery, or lucidity) remains unclear.

Keywords:
Nightmare treatment, Lucid dreaming therapy
1.
Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S: Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979;79:1257–1262.
2.
Klink M, Quan S: Prevalence of reported sleep disturbances in a general population and their relation to obstructive airway disease. Chest 1987;91:540–546.
3.
Stepansky R, Holzinger B, Schmeiser-Rieder A, Saletu B, Kunze M, Zeitlhofer J: Austrian dream behavior: results of a representative population survey. Dreaming 1998;8:23–31.
4.
Hublin C, Kaprio J, Partinen M, Koskenvuo M: Nightmares: familial aggregation and association with psychiatric disorders in a nationwide twin cohort. Am J Med Gen 1999;88:329–336.
5.
Faravelli C, Abrardi L, Bartolozzi D, Cecchi C, Cosci F, D’Adamo D, Lo Iacone B, Ravaldi C, Scarpato MA, Truglia E, Rossi Prodi PM, Rosi S: The Sesto Fiorentino study: point and one-year prevalences of psychiatric disorders in an Italian community sample using clinical interviewers. Psychother Psyc hosom 2004;73:226–234.
6.
Wittchen HU: Continued needs for epidemiological studies of mental disorders in the community. Psychother Psychosom 2004;73:197–206.
7.
Kales A, Soldatos CR, Caldwell AB, Charney DS, Kales JD, Markel D, Cadieux R: Nightmares: clinical characteristics and personality patterns. Am J Psychiatry 1980;137:1197–1201.
8.
Krakow B, Tandberg D, Scriggins L: A controlled comparison of self-rated sleep complaints in acute and chronic nightmares sufferers. J Nerv Ment Dis 1995;183:623–627.
9.
Berquier A, Ashton R: Characteristics of the frequent nightmare sufferer. J Abnorm Psychol 1992;101:246–250.
10.
Zadra AL, Donderi DC: Nightmares and bad dreams: their prevalence and relationship to well-being. J Abnorm Psychol 2000;109:273–281.
11.
Köthe M, Pietrowsky R: Behavioral effects of nightmares and their correlations to personality patterns. Dreaming 2001;11:43–52.
12.
Haynes SN, Mooney DK: Nightmares: etiological, theoretical, and behavioral treatment considerations. Psychol Rec 1975;25:225–236.
13.
Krakow B, Melendrez D, Pedersen B, Johnston L, Hollifield M, Germain A, Koss M, Warner TD, Schrader R: Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD. Biol Psychiatry 2001;49:948–953.
14.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text rev. Washington, American Psychiatric Press, 2000.
15.
Schreuder JN, Kleijn WC, Rooijmans HGM: Nocturnal re-experiencing more than forty years after war trauma. J Traum Stress 2000;13:453–463.
16.
Neidhardt EJ, Krakow BJ, Kellner R, Pathak D: The beneficial effects of one treatment session and recording of nightmares on chronic nightmare sufferers. Sleep 1992;15:470–473.
17.
Miller WR, DiPilato M: Treatment of nightmares via relaxation and desensitization: a controlled evaluation. J Consult Clin Psychol 1983;51:870–877.
18.
Celluci AJ, Lawrence PS: The efficacy of systematic desensitization in reducing nightmares. J Behav Ther Exp Psychiatry 1978;9:109–114.
19.
Burgess M, Marks IM, Gill M: Postal self-exposure treatment of recurrent nightmares. Br J Psychiatry 1994;165:388–391.
20.
Burgess M, Gill M, Marks IM: Postal self exposure treatment of recurrent nightmares: a randomised controlled trial. Br J Psychiatry 1998;172:257–262.
21.
Krakow B, Kellner R, Pathak D, Lambert L: Imagery rehearsal treatment for chronic nightmares. Behav Res Ther 1995;33:837–843.
22.
Marks I: Rehearsal relief of a nightmare. Br J Psychiatry 1978;135:461–465.
23.
Krakow B, Hollifield M, Schrader R: A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. J Trauma Stress 2000;13:589–609.
24.
Krakow B, Hollifield M, Johnston L, Koss M, Schrader R, Warner TD, Tandberg D, Luariello J, McBride L: Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA 2001;286:537–545.
25.
LaBerge S, Nagel LE, Dement WC, Zarcone VP: Lucid dreaming verified by volitional communication during REM sleep. Percept Motor Skills 1981;52:727–732.
26.
Purcell S, Mullington J, Moffit A, Hoffman R, Pigeau R: Dream self-reflectiveness as a learned cognitive skill. Sleep 1986;9:423–437.
27.
Zadra AL, Donderi DC, Pihl RO: Efficacy of lucid dream induction for lucid and non-lucid dreamers. Dreaming 1992;2:85–97.
28.
Schredl M, Erlacher D: Lucid dreaming frequency and personality. Pers Ind Differ 2004;37:1463–1473.
29.
Wolpin M, Marston A, Randolph C, Clothies A: Individual differences correlates of reported lucid dreaming frequency and control. J Ment Imag 1992;16:231–236.
30.
Halliday G: Direct psychological therapies for nightmares: a review. Clin Psychol Rev 1987;7:501–523.
31.
Zadra AL, Pihl RO: Lucid dreaming as a treatment for recurrent nightmares. Psychother Psychosom 1997;66:50–55.
32.
Spoormaker VI, van den Bout J, Meijer EJG: Lucid dreaming treatment for nightmares: a series of cases. Dreaming 2003;13:181–186.
33.
Ohayon MM, Priest RG, Guilleminault C, Caulet M: Nightmares: their relationships with mental disorders and sleep disorders. Eur Neuropsychopharmacol 1996;6(suppl 3):136–137.
34.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Press, 1994.
35.
Schredl M, Piel E: Gender differences in dream recall frequency: data from our representative German samples. Pers Ind Differ 2003;35:1185–1189.
36.
Spoormaker VI, Verbeek I, van den Bout J, Klip EC: Initial validation of the SLEEP-50 questionnaire. Behav Sleep Med 2005;3:227–246.
37.
Fisher C, Byrne J, Edwards A, Kahn E: A psychophysiological study of nightmares. J Am Psychoanal Assoc 1970;18:747–782.
38.
Zadra AL, Donderi DC: Nightmares and bad dreams: their prevalence and relationship to well-being. J Abnorm Psychol 2000;109:273–281.
39.
Spoormaker VI, Schreuder JN, Kamphuisen HAC, Kleijn WC: Does polysomnography reduce nightmare frequency? Paper presented 21st Annu ASD Conf, Copenhagen, 2004.
40.
Hovens JE, Bramsen I, van der Ploeg HM: Manual for the Self-Rating Inventory for Posttraumatic Stress Disorder (SRIP). Lisse, Swets Test Publishers, 2000.
41.
Marks IM: Fears, Phobias, and Rituals. New York, Oxford University Press, 1987, pp 392–394.
42.
Tholey P: A model of lucidity training as a means of self-healing and psychological growth; in Gackenbach J, LaBerge S (eds): Conscious Mind, Sleeping Brain. New York, Plenum, 1988, pp 263–287.
43.
Germain A, Krakow B, Faucher B, Zadra A, Nielsen T, Hollifield M, Warner TD, Koss M: Increased mastery elements associated with imagery rehearsal treatment for nightmares in sexual assault survivors with PTSD. Dreaming 2004;14:195–206.
44.
Hall CS, Van de Castle R: The Content Analysis of Dreams. New York, Appleton-Century-Crofts, 1966.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.